Gillmore, J. D. et al., CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis (2021)

https://doi.org/10.1056/NEJMoa2107454

Authors. Gillmore, J. D. et al.

Venue. New England Journal of Medicine

How the Institute flags it

frontier 2 times

Cited on 2 pages

• CRISPR and editing in vivo
• Lipid nanoparticles